The robotic radiotherapy market has seen considerable growth due to a variety of factors.
• The market size of robotic radiotherapy has seen incredibly fast expansion in the last few years. Predicted growth stands at an increase from $1.06 billion in 2024 to a staggering $1.17 billion in 2025 with a compound annual growth rate (CAGR) at a robust rate of 10.9%.
The substantial growth experienced in this historical time frame can be credited to the enhancements made in robotic system precision, the incorporation of AI in treatment strategies, better access to healthcare, a greater emphasis on treatments tailored to the individual patient, and increased influx of investments in the private healthcare sector.
The robotic radiotherapy market is expected to maintain its strong growth trajectory in upcoming years.
• The market for robotic radiotherapy is anticipated to experience substantial growth in the upcoming years, likely reaching $1.75 billion by 2029 with a 10.6% compound annual growth rate (CAGR). This surging expansion is projected due to a rise in the ageing global population, innovative strides in machine learning utilized for treatment planning, a growing fondness for outpatient procedures, the broadening of robotic-assisted surgical systems, and a surge in partnerships between tech firms and healthcare providers. Noteworthy trends include enhancements in motion management systems, the expansion of cloud-based radiotherapy platforms, the incorporation of wearable technology for patient observation, the design of smaller yet more powerful robotic systems, and increased application of stereotactic radiosurgery techniques.
The growth of the robotic radiotherapy market is set to be fueled by the increasing need for minimally invasive procedures. The advancement in medical technology, along with a growing preference among patients for shorter recovery times and fewer complications, has driven these procedures. Similarly, the cost-effectiveness and improved clinical outcomes make them a popular choice among healthcare providers. Robotic radiotherapy intensifies the precision and efficacy of such procedures by directing a concentrated dosage of radiation to tumors, which in turn, minimizes damage to healthy tissues nearby. This method lowers complications, improves recovery times, and fulfills the increasing demand for advanced, patient-focused treatment options. For instance, down the timeline in June 2024, the American Society of Plastic Surgeons highlights that a medication company based in the US saw a 7% growth in minimally invasive procedures in 2023 compared to the previous year. Hence, the heightened need for such procedures is propelling the growth of the robotic radiotherapy market.
The robotic radiotherapy market covered in this report is segmented –
1) By Product: Radiotherapy Systems, Softwares, 3D Cameras (Surface Guided)
2) By Technology: Linear Accelerators, Conventional Linear Accelerators, Magnetic Resonance Imaging (MRI) - Linear Accelerators, Stereotactic Radiation Therapy Systems, Cyberknife, Gamma Knife, Particle Therapy, Proton Beam Therapy
3) By Application: Prostate Cancer, Breast Cancer, Lung Cancer, Head & Neck Cancer, Colorectal Cancer
4) By End User: Hospitals, Independent Radiotherapy Centers
Subsegments:
1) By Radiotherapy Systems: Robotic Linear Accelerators, Proton Therapy Systems, Stereotactic Radiosurgery Systems, Image-Guided Radiotherapy (IGRT) Systems, Intensity-Modulated Radiotherapy (IMRT) Systems
2) By Softwares: Treatment Planning Software, Radiation Therapy Management Software, Robotic Radiotherapy Control Software, Integration Software For Robotic Systems
3) By 3D Cameras (Surface Guided): 3D Optical Surface Imaging Systems, 3D Camera Systems For Patient Positioning, 3D Motion Tracking Cameras For Radiotherapy, Real-Time 3D Surface Imaging For Tumor Localization
Key players in the robotic radiotherapy market are concentrating on creating groundbreaking products with cutting-edge technology like artificial intelligence (AI) precision. This technology enhances the accuracy by reducing human errors, improving uniformity, minimizing tissue harm, and speeding up recovery thanks to sensors, actuators, and algorithms. For example, in January 2024, the US-based cancer centre, Tampa General Hospital, unveiled the CyberKnife S7, a radiosurgery tool powered by AI. This new technology represents a significant advancement in cancer treatment, offering a non-invasive and precise treatment alternative for various conditions, including both benign and malignant tumours, as well as neurological disorders. The CyberKnife S7 ensures targeted radiation delivery, minimizing harm to surrounding healthy tissues and providing a less invasive option than traditional surgical methods.
Major companies operating in the robotic radiotherapy market are include:
• Panasonic Healthcare
• Siemens Healthineers AG
• Fujifilm Medical Systems
• GE Healthcare Technologies Inc.
• Varian Medical Systems
• Kuka AG
• Elekta AB
• Accuray Incorporated
• Brainlab AG
• Mevion Medical Systems Inc.
• ViewRay Technologies Inc.
• RaySearch Laboratories AB
• VisionRT Ltd.
• MIM Software Inc.
• CIVCO Radiotherapy
• ProNova Solutions
• IntraOp Medical Corporation
• IBA Group
• Xcision Medical Systems LLC
• C-RAD AB
North America was the largest region in the robotic radiotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the robotic radiotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.